KZR: Kezar Life Sciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.66
Enterprise Value ($M) -1.76
Book Value ($M) 116.92
Book Value / Share 16.00
Price / Book 0.25
NCAV ($M) 109.72
NCAV / Share 15.02
Price / NCAV 0.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 6.76
Current Ratio 6.76

Balance Sheet (mrq) ($M)
Current Assets 137.49
Assets 144.68
Liabilities 27.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -89.14
Net Income -83.74
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -74.21
Cash from Investing 80.43
Cash from Financing 0.10

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Avidity Partners Management LP
10-08 13D Tang Capital Management Llc 9.90
07-08 13G/A BlackRock, Inc. 1.10 -82.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 2,280 6,109 37.32
2025-04-16 2,706 18,296 14.79
2025-04-15 1,044 31,572 3.31
2025-04-14 4,893 23,942 20.44

(click for more detail)

Similar Companies
KPRX – Kiora Pharmaceuticals, Inc. KRRO – Korro Bio, Inc.
KTTA – Pasithea Therapeutics Corp. LEXX – Lexaria Bioscience Corp.
LFVN – LifeVantage Corporation


Financial data and stock pages provided by
Fintel.io